Newbridge Financial Services Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.86K | Sell |
45
-450
| -91% | -$98.6K | ﹤0.01% | 891 |
|
|
2025
Q1 | $111K | Buy |
495
+450
| +1,000% | +$101K | 0.03% | 252 |
|
|
2024
Q4 | $14.7K | Buy |
+45
| New | +$14.7K | ﹤0.01% | 668 |
|
|
2024
Q3 | – | Sell |
-45
| Closed | -$14.8K | – | 1129 |
|
|
2024
Q2 | $14.8K | Buy |
45
+17
| +61% | +$5.6K | 0.01% | 632 |
|
|
2024
Q1 | $11.1K | Hold |
28
| – | – | ﹤0.01% | 743 |
|
|
2023
Q4 | $9.86K | Hold |
28
| – | – | ﹤0.01% | 739 |
|
|
2023
Q3 | $10.5K | Hold |
28
| – | – | 0.01% | 810 |
|
|
2023
Q2 | $10.7K | Hold |
28
| – | – | 0.01% | 873 |
|
|
2023
Q1 | $9.7K | Buy |
+28
| New | +$9.7K | 0.01% | 919 |
|
|
2021
Q3 | – | Sell |
-12
| Closed | -$4K | – | 1628 |
|
|
2021
Q2 | $4K | Hold |
12
| – | – | ﹤0.01% | 1184 |
|
|
2021
Q1 | $3K | Hold |
12
| – | – | ﹤0.01% | 1137 |
|
|
2020
Q4 | $3K | Sell |
12
-36
| -75% | -$9K | ﹤0.01% | 938 |
|
|
2020
Q3 | $13K | Buy |
+48
| New | +$13K | 0.01% | 619 |
|